Weiyao Kong - Concepedia

Author

Weiyao Kong

Guangzhou Medical University ORCID

Also Known As

Wei-Yao Kong, Wei-yao Kong, Weiyao Kong

Publications

305

Citations

H-Index

Concepts

All Affiliations

Guangzhou Medical University Peking University Cancer Hospital Peking University First People's Hospital of Foshan National Center for Nanoscience and Technology

About

Weiyao Kong is an author at Guangzhou Medical University specializing in tumor biology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	82
2	Cell Biology	2	2	58
3	Engineering	1	1	37
4	Biomedical Engineering	1	1	37
5	Hepatology	1	1	24

Weiyao Kong

Publications

276

Citations

H-Index

Page 1

	Year	Citations
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells Yuning Liao, Zhenlong Shao, Yuan Liu, Journal of Experimental & Clinical Cancer Research	2021	54
Noninvasive Diagnosis and Molecular Phenotyping of Breast Cancer through Microbead‐Assisted Flow Cytometry Detection of Tumor‐Derived Extracellular Vesicles Wenzhe Li, Bin Shao, Changliang Liu, Small Methods Breast OncologyEngineeringExtracellular MicrovesiclesBiomedical EngineeringTumor Biology	2018	37
HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma Yuning Liao, Yuan Liu, Cuifu Yu, Advanced Science	2023	37
Selective degradation of AR-V7 to overcome castration resistance of prostate cancer Yuan Liu, Cuifu Yu, Zhenlong Shao, Cell Death and Disease	2021	36
Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patients Xiaoran Liu, Bin Shao, Jiaxi Peng, The Breast	2017	24
SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16 Yuan Liu, Weiyao Kong, Cuifu Yu, Acta Pharmacologica Sinica HepatologyOncogenic AgentCancer Drivers Six1PathologyLiver Cancer	2022	24
Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression Xiaohong Xia, Tumei Hu, Xiaoyue He, International Journal of Biological Sciences Tumor BiologyBreast OncologySignal TransductionHer2 ExpressionCell Regulation	2022	21
Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer Xiaoran Liu, Ran Ran, Bin Shao, Chinese Journal of Cancer Research	2018	19
Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing Nan Wang, Kun Li, Wenfa Huang, Chinese Journal of Cancer Research	2020	14
Identification of recurrent<scp>BRCA</scp>1 mutation and its clinical relevance in Chinese Triple‐negative breast cancer cohort Xiaoran Liu, Huiping Li, Bin Shao, Cancer Medicine	2017	10

Page 1